Seaport Therapeutics, a clinical-stage biopharmaceutical company focused on novel neuropsychiatric medicines, has secured $225 million in an oversubscribed Series B funding round. This significant financing effort was led by General…
© 2023 Copyright dailytechnewsweb.com